###begin article-title 0
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts
###end article-title 0
###begin p 1
Conceived and designed the experiments: EH JB MC JW. Performed the experiments: AG AP MN BP CF TL LM MD MJ SK DB. Analyzed the data: JB AP HC JW. Wrote the paper: JB AP JW.
###end p 1
###begin p 2
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 993 994 993 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1159 1160 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1230 1235 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1325 1330 1325 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1502 1507 1502 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1585 1590 1585 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1739 1744 1739 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 912 920 <span type="species:ncbi:9606">patients</span>
###xml 1033 1041 <span type="species:ncbi:9606">patients</span>
###xml 1074 1082 <span type="species:ncbi:9606">patients</span>
###xml 1100 1108 <span type="species:ncbi:9606">patients</span>
Refractory Anemia with Ring Sideroblasts (RARS) is an acquired myelodysplastic syndrome (MDS) characterized by an excess iron accumulation in the mitochondria of erythroblasts. The pathogenesis of RARS and the cause of this unusual pattern of iron deposition remain unknown. We considered that the inherited X-linked sideroblastic anemia with ataxia (XLSA/A) might be informative for the acquired disorder, RARS. XLSA/A is caused by partial inactivating mutations of the ABCB7 ATP-binding cassette transporter gene, which functions to enable transport of iron from the mitochondria to the cytoplasm. Furthermore, ABCB7 gene silencing in HeLa cells causes an accumulation of iron in the mitochondria. We have studied the role of ABCB7 in RARS by DNA sequencing, methylation studies, and gene expression studies in primary CD34+ cells and in cultured erythroblasts. The DNA sequence of the ABCB7 gene is normal in patients with RARS. We have investigated ABCB7 gene expression levels in the CD34+ cells of 122 MDS cases, comprising 35 patients with refractory anemia (RA), 33 patients with RARS and 54 patients with RA with excess blasts (RAEB), and in the CD34+ cells of 16 healthy controls. We found that the expression levels of ABCB7 are significantly lower in the RARS group. RARS is thus characterized by lower levels of ABCB7 gene expression in comparison to other MDS subtypes. Moreover, we find a strong relationship between increasing percentage of bone marrow ring sideroblasts and decreasing ABCB7 gene expression levels. Erythroblast cell cultures confirm the low levels of ABCB7 gene expression levels in RARS. These data provide an important link between inherited and acquired forms of sideroblastic anemia and indicate that ABCB7 is a strong candidate gene for RARS.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 186 189 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Heaney1">[1]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Greenberg1">[2]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Cazzola1">[3]</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Breccia1">[4]</xref>
The myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic malignancies, characterized by blood cytopenias, ineffective hematopoiesis and a hypercellular bone marrow [1]. Refractory Anemia with Ring Sideroblasts (RARS) is a subtype of MDS in which excess iron accumulates in the form of aberrant mitochondrial ferritin in the mitochondria of the erythroid precursors [2], [3]. RARS is a myeloid malignancy and transforms to acute leukemia in approximately 10-20% of cases [4]. The molecular genetic basis of RARS remains unknown.
###end p 4
###begin p 5
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Hines1">[5]</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Furuyama1">[7]</xref>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALAS2</italic>
###xml 408 411 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Cotter1">[8]</xref>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Bekri1">[9]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Allikmets1">[10]</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Shimada1">[11]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Kispal1">[12]</xref>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pondarre1">[13]</xref>
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pondarre1">[13]</xref>
###xml 1121 1125 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Cavadini1">[14]</xref>
###xml 1255 1259 1255 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pondarre1">[13]</xref>
###xml 1289 1294 1289 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Cavadini1">[14]</xref>
###xml 1405 1410 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 625 630 <span type="species:ncbi:4932">yeast</span>
###xml 1250 1254 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The hereditary sideroblastic anemias are a heterogeneous group of disorders characterized by the presence of ring sideroblasts in the bone marrow, microcytic hypochromic anemia and typically show X-linked inheritance [5]-[7]. Many of the reported cases of inherited X-linked sideroblastic anemia have been found to be caused by mutations in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) [8]. A rare inherited X-linked sideroblastic anemia with ataxia (XLSA/A) is caused by mutations of the mitochondrial ATP-binding cassette transporter ABCB7[9], [10]. The ABCB7 gene is the functional orthologue of the yeast Atm1p gene [11], which is required for mitochondrial iron homeostasis [12] and has been implicated in the transport of a component required for the maturation of iron-sulfur (Fe-S) cluster proteins out of mitochondria [13]. It has been demonstrated that XLSA/A is due to partial loss of function mutations in ABCB7 that directly or indirectly inhibit heme biosynthesis [13]. The anemia in XLSA/A is caused by the accumulation of iron in a form that is not readily usable for heme synthesis [14]. Moreover, ABCB7 has been demonstrated to be essential for hematopoiesis in experiments using conditional gene targeting in mice [13]. In an important experiment, ABCB7 has been silenced in HeLa cells by sequential transfection experiments with siRNAs [14]. The phenotype of the ABCB7-deficient cells was characterized by a reduction in proliferation rate that was not rescued by iron supplementation, by signs of iron deficiency, and by a large increase of iron accumulation in the mitochondria that was poorly available to mitochondrial ferritin.
###end p 5
###begin p 6
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
We have investigated the expression levels of the ABCB7 gene using data from our large microarray dataset on CD34+ cells from MDS patients and healthy controls in order to determine whether the ABCB7 gene is implicated in the common acquired sideroblastic anemia, RARS.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Sample collection and cell separation
###end title 8
###begin p 9
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Bennett1">[15]</xref>
###xml 889 890 889 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 244 251 <span type="species:ncbi:9606">patient</span>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
###xml 871 883 <span type="species:ncbi:9606">participants</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
122 patients with MDS and 16 healthy controls were included in the study. Classification of MDS patients was according to the French-American-British (FAB) criteria [15] and the patients were selected solely on the basis of having MDS. The MDS patient samples were obtained from several sources: Oxford, Bournemouth and Dundee (United Kingdom), Stockholm (Sweden), Duisburg (Germany) and Pavia (Italy). At the time of investigation, 35 patients had Refractory Anemia (RA), 33 RARS and 54 Refractory Anemia with Excess Blasts (RAEB). The study was approved by the ethical committees of the John Radcliffe Hospital (Oxford), the Karolinska Institutet (Stockholm), the IRCCS Policlinico S. Matteo (Pavia), the Royal Bournemouth Hospital (Bournemouth), the St Johannes Hospital (Duisburg) and the Ninewells Hospital (Dundee); written informed consent was obtained from study participants. CD34+ cells were isolated from the bone marrow samples of MDS patients and healthy controls using MACS magnetic cell separation columns (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's recommendations.
###end p 9
###begin title 10
Erythroblast cell cultures
###end title 10
###begin p 11
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pellagatti1">[16]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Tehranchi1">[17]</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
CD34+ cells isolated from the bone marrow of 8 patients with RARS, 9 patients with RA and 8 healthy controls were cultured according to a method developed to study the generation of erythroblasts [16], [17]. Gene expression profiling experiments were performed on cultured cells at day 7.
###end p 11
###begin title 12
Microarray experiments and data analysis
###end title 12
###begin p 13
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pellagatti2">[18]</xref>
###xml 121 126 <span type="species:ncbi:9606">Human</span>
Gene expression profiling experiments and data analysis were performed as previously described [18]. Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays (47,000 transcripts) were used. Gene correlations were calculated using Pearson correlation.
###end p 13
###begin title 14
Real-time quantitative PCR
###end title 14
###begin p 15
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pellagatti1">[16]</xref>
###xml 395 396 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 404 408 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Livak1">[19]</xref>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Real-time quantitative PCR for the ABCB7 gene was performed using cDNA made from the unamplified RNA from CD34+ cells of 7 patients with RARS, 8 patients with RA, 6 patients with RAEB and 7 healthy controls. Beta-2-microglobulin was used to normalize for differences in input cDNA. Reactions were performed as previously described [16] and expression ratios were calculated using the DeltaDeltaCT method [19].
###end p 15
###begin title 16
Statistical analysis
###end title 16
###begin p 17
Statistical analysis and box plots were created using StatView software. Kruskal-Wallis test was used for comparison between three or more groups and Mann-Whitney U test for comparisons between any two groups. A P-value <0.01 was considered significant.
###end p 17
###begin title 18
DNA sequencing
###end title 18
###begin p 19
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Direct sequencing of ABCB7 was performed on DNA from 13 RARS patients using Applied Biosystems Big dye terminator kit v1.1.
###end p 19
###begin title 20
Promoter methylation studies
###end title 20
###begin p 21
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 595 621 595 621 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTTTGGGGTTTTGGGAAAAT-3&#8242;</named-content>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 649 681 649 681 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCCATATCAATAACATCTCACCTAA-3&#8242;</named-content>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 1009 1014 1009 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
We looked at promoter methylation of ABCB7 in DNA samples from 6 RARS patients (2 bone marrow, 2 neutrophil and 2 CD34+ samples) and from 5 healthy controls (1 bone marrow, 1 neutrophil, 1 mononuclear cell and 2 CD34+ samples). The ABCB7 promoter was predicted using PromoterScan and CpGPlot software. For investigation of methylation status we used bisulphite sequencing. Bisulphite modification of the genomic DNA was carried out using the EpiTect Bisulphite kit (Qiagen). Primers to amplify the modified DNA for bisulphite sequencing were designed using Primer3 software and were as follows: 5'-GTTTGGGGTTTTGGGAAAAT-3' (ABCB7 forward primer) and 5'-TTCCATATCAATAACATCTCACCTAA-3' (ABCB7 reverse primer). The PCR products were purified with the Wizard PCR Clean-Up System and Vacuum Manifold (Promega, Madison, WI) according to the manufacturer's instructions. PCR products were cloned using the pGEM-T Easy cloning system (Clontech) and sequenced with Applied Biosystems Big dye terminator kit v1.1 and the ABCB7 forward primer.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
ABCB7 expression levels in MDS subtypes
###end title 23
###begin p 24
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 336 343 336 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001970-t001">Table 1</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001970-g001">Figure 1A</xref>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
We have determined the ABCB7 gene expression levels from our microarray dataset on CD34+ cells in 122 MDS patients and 16 healthy controls. We have compared the gene expression levels of ABCB7 between 35 patients with refractory anemia (RA), 33 patients with RARS, 54 patients with RA and excess blasts (RAEB), and 16 healthy controls (Table 1; Figure 1A). The expression levels of ABCB7 are lowest in the RARS group compared to RA (p<0.0001), RAEB (p<0.0001) and healthy controls (p<0.0001). No significant difference was observed between the RA, RAEB and healthy control groups.
###end p 24
###begin title 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
ABCB7 expression levels.
###end title 25
###begin p 26
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 331 333 331 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 337 339 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 346 348 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 400 402 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 278 286 <span type="species:ncbi:9606">patients</span>
(A) ABCB7 expression levels in the CD34+ cells from healthy controls and MDS patients with RA, RAEB and RARS. (B) ABCB7 expression levels and percentage of ring sideroblasts in the bone marrow. (C) ABCB7 expression levels in cultured erythroblasts from healthy controls and MDS patients with RA and RARS. The boxes represent the 25th, 50th and 75th percentiles, the bars correspond to the 10th and 90th percentiles.
###end p 26
###begin title 27
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Descriptive statistics of ABCB7 expression levels in CD34+ cells according to FAB group, in CD34+ cells according to percentage of bone marrow ring sideroblasts, and in cultured erythroblasts at day 7.
###end title 27
###begin title 28
ABCB7 expression levels and percentage of bone marrow ring sideroblasts
###end title 28
###begin p 29
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001970-t001">Table 1</xref>
###xml 225 234 225 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001970-g001">Figure 1B</xref>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001970-t001">Table 1</xref>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
The 101 of 122 MDS cases, where data was available on the exact percentage of bone marrow ring sideroblasts, have been divided in three groups by percentage of bone marrow ring sideroblasts (0-14%, 15-40% and >41%) (Table 1; Figure 1B). It can be seen that the median expression level of ABCB7 falls progressively across the three groups. As shown in Table 1, the differences in ABCB7 expression between the three groups are all statistically significant.
###end p 29
###begin title 30
ABCB7 expression levels in erythroblast cultures
###end title 30
###begin p 31
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pellagatti1">[16]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Tehranchi1">[17]</xref>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 506 513 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001970-t001">Table 1</xref>
###xml 515 524 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001970-g001">Figure 1C</xref>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
In addition, we have studied the ABCB7 gene expression levels in erythroblast cultures derived from the CD34+ cells of 8 patients with RARS, 9 patients with RA and 8 healthy controls. Cells were cultured according to a method developed to study the generation of erythroblasts [16], [17] and gene expression profiling experiments were performed on cultured cells at day 7. We confirmed the low levels of ABCB7 gene expression levels in RARS erythroblasts in comparison to those of RA and healthy controls (Table 1; Figure 1C).
###end p 31
###begin title 32
Confirmation of ABCB7 expression data
###end title 32
###begin p 33
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 241 249 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001970-g002">Figure 2</xref>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
The microarray-generated expression data of the ABCB7 gene were validated and confirmed in a subset of 21 MDS patients (7 patients with RARS, 8 patients with RA, 6 patients with RAEB) and 7 healthy controls using real-time quantitative PCR (Figure 2). A high concordance was observed between the expression levels obtained with Affymetrix chips and with real-time quantitative PCR, indicating a good level of agreement between the two assays.
###end p 33
###begin title 34
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
Confirmation of the microarray data for the ABCB7 gene using real-time quantitative PCR.
###end title 34
###begin title 35
ABCB7 gene sequencing and promoter methylation
###end title 35
###begin p 36
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
Direct sequencing of ABCB7, including the promoter region, was performed on DNA from 13 RARS patients and did not show any mutations in any of the patients. We have investigated the methylation status of the ABCB7 promoter region in 6 patients with RARS and 5 healthy controls, and the results showed >80% methylation in all samples, with no significant difference between RARS patients and healthy controls.
###end p 36
###begin title 37
ABCB7 gene correlation
###end title 37
###begin p 38
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 224 229 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 317 322 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 335 339 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELP2</italic>
###xml 351 355 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RTF1</italic>
###xml 427 432 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
No genomic abnormality in the ABCB7 gene was identified in our cases. Therefore, we examined our microarray dataset for genes with expression levels correlated either strongly positively (>/=0.8) or inversely (</=-0.8) with ABCB7 gene expression levels. The expression of two genes showed a positive correlation with ABCB7 expression: ELP2 (0.82) and RTF1 (0.80). No genes were found whose expression correlated inversely with ABCB7.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Steensma1">[20]</xref>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
We have examined the role of ABCB7, the gene involved in the hereditary XLSA/A, in the acquired RARS syndrome. The hypothesis under consideration is that XLSA/A and acquired RARS may have a shared molecular basis. Interestingly, there is an excess of erythrocyte protoporphyrin in XLSA/A (in contrast with other types of genetic sideroblastic anemia) as also found in RARS [20]. We have determined the ABCB7 gene expression levels from our microarray dataset on CD34+ cells in 122 MDS patients and 16 healthy controls. The expression levels of ABCB7 are significantly lower in the RARS group than in healthy controls, RA or RAEB. In contrast there is no significant difference in ABCB7 expression between the latter three groups.
###end p 40
###begin p 41
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
The definition of RARS includes more than 15% ring sideroblasts in the bone marrow. However, we find not only lower levels of ABCB7 in RARS than other MDS but also a progressive reduction of ABCB7 expression as the percentage of ring sideroblasts increases. In addition, we have studied the ABCB7 gene expression levels in erythroblast cultures and confirmed the low levels of ABCB7 gene expression levels in RARS erythroblasts in comparison to those of RA and healthy controls.
###end p 41
###begin p 42
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Steensma1">[20]</xref>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
The gene expression levels of ABCB7 were validated and confirmed in a subset of MDS patients and healthy controls using real-time quantitative PCR. Direct sequencing of ABCB7, including the promoter region, was performed on DNA from 13 RARS patients and did not show any mutations in any of the patients. Similarly, Steensma et al, in a recent study, found no coding mutations of ABCB7 in patients with RARS [20].
###end p 42
###begin p 43
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Weber1">[21]</xref>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Weber1">[21]</xref>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
We have investigated the methylation status of the ABCB7 promoter region and the results showed >80% methylation in all samples, with no significant difference between RARS patients and healthy controls. Gene promoters can be divided into three groups according to their CpG ratio, GC content and length of CpG-rich region: high-CpG, intermediate-CpG and low-CpG promoters [21]. Based on this classification, the ABCB7 promoter region is defined as an intermediate-CpG promoter. Intermediate-CpG promoters show a high frequency of DNA methylation [21]. Our data fit with the definition of the ABCB7 promoter region as an intermediate CpG promoter, but suggest that promoter methylation is unlikely to be the mechanism underlying the reduction in expression levels of ABCB7 observed in RARS.
###end p 43
###begin p 44
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATRX</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Gibbons1">[22]</xref>
###xml 469 474 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 557 562 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 619 623 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELP2</italic>
###xml 635 639 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RTF1</italic>
###xml 700 704 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Warner1">[23]</xref>
###xml 706 710 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Krogan1">[24]</xref>
###xml 799 803 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Kim1">[25]</xref>
No genomic abnormality in the ABCB7 gene was identified in our cases, suggesting that there could be a trans-acting factor responsible for the low levels of ABCB7 in RARS (analogous to the down regulation of the alpha-globin genes in the acquired HbH associated with MDS caused by mutations in the ATRX gene) [22]. Therefore, we examined our microarray dataset for genes with expression levels correlated either strongly positively (>/=0.8) or inversely (</=-0.8) with ABCB7 gene expression levels. While no other gene had a strong inverse correlation with ABCB7, interestingly two genes showed a positive correlation: ELP2 (0.82) and RTF1 (0.80), both of which are associated with RNA Polymerase II [23], [24]. Deregulation of these factors may cause defective gene transcription through chromatin [25].
###end p 44
###begin p 45
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Pondarre1">[13]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Cavadini1">[14]</xref>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001970-Oscarson1">[26]</xref>
###xml 991 996 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB7</italic>
###xml 340 344 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 898 906 <span type="species:ncbi:9606">patients</span>
The existence of an inherited disorder XLSA/A caused by inactivating mutations in ABCB7 is, of course, very informative of the probable consequences of reduced expression of the same gene in acquired disorders. Many of the key properties of ABCB7 have already been established by gene silencing studies and by conditional gene targeting in mice [13], [14]. All of these experiments are consistent with the importance of ABCB7 in hematopoiesis and with the observed phenotype in XLSA/A. Therefore, it would be predicted that erythroblasts with low ABCB7 levels would have abnormal mitochondrial iron homeostasis. Our finding of a strong association between RARS and low gene expression levels of ABCB7 also raises the possibility of therapeutic approaches for RARS using drugs which induce the expression of ABCB7, for example, carbamazepine has been shown to induce ABCB7 in the liver of epileptic patients treated with the drug [26]. We suggest that down-regulation of the iron transporter ABCB7 plays an important role in the molecular pathogenesis of RARS, making an intriguing link between the inherited and acquired forms of sideroblastic anemia.
###end p 45
###begin p 46
We are grateful to the Tayside Cancer Tissue Bank (Dundee, UK) for samples.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Myelodysplasia.
###end article-title 48
###begin article-title 49
Myelodysplastic syndromes.
###end article-title 49
###begin article-title 50
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
###end article-title 50
###begin article-title 51
Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes.
###end article-title 51
###begin article-title 52
The sideroblastic anemias.
###end article-title 52
###begin article-title 53
Familial sideroblastic anaemia: problem of Xg and X chromosome inactivation.
###end article-title 53
###begin article-title 54
Multiple mechanisms for hereditary sideroblastic anemia.
###end article-title 54
###begin article-title 55
X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley.
###end article-title 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation.
###end article-title 56
###begin article-title 57
Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A).
###end article-title 57
###begin article-title 58
Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia.
###end article-title 58
###begin article-title 59
The ABC transporter Atm1p is required for mitochondrial iron homeostasis.
###end article-title 59
###begin article-title 60
Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis.
###end article-title 60
###begin article-title 61
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload.
###end article-title 61
###begin article-title 62
Proposals for the classification of the myelodysplastic syndromes.
###end article-title 62
###begin article-title 63
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
###end article-title 63
###begin article-title 64
Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.
###end article-title 64
###begin article-title 65
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
###end article-title 65
###begin article-title 66
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 66
###begin article-title 67
Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).
###end article-title 67
###begin article-title 68
###xml 93 98 <span type="species:ncbi:9606">human</span>
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
###end article-title 68
###begin article-title 69
Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
###end article-title 69
###begin article-title 70
Rtf1 is a multifunctional component of the Paf1 complex that regulates gene expression by directing cotranscriptional histone modification.
###end article-title 70
###begin article-title 71
###xml 118 142 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Characterization of a six-subunit holo-elongator complex required for the regulated expression of a group of genes in Saccharomyces cerevisiae.
###end article-title 71
###begin article-title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Elongator facilitates RNA polymerase II transcription through chromatin.
###end article-title 72
###begin article-title 73
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine.
###end article-title 73
###begin p 74
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 74
###begin p 75
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Leukaemia Research Fund of the UK, and in part by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro), Milan, and Fondazione IRCCS Policlinico San Matteo, Pavia, to M.C.
###end p 75

